Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of a Mobile Remote Device to Optimize Pediatric Inter-facility Transportation: A Feasibility Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02915640
Recruitment Status : Completed
First Posted : September 27, 2016
Last Update Posted : September 27, 2016
Sponsor:
Information provided by (Responsible Party):
Tanya Holt, University of Saskatchewan

Brief Summary:
This study compares the utilization of remote technology versus not using remote technology when triaging and managing pediatric patients in remote settings prior to pediatric specialized inter-facility transportation.

Condition or disease Intervention/treatment Phase
Acute Disease Other: Remote technology Not Applicable

Detailed Description:

Paediatric Specialized Inter-facility transport utilizes specialized teams usually made up of a respiratory therapist, paediatric critical care nurse, and paediatric intensivist as medical control. When a Nurse Practitioner or General Practitioner from a remote site has a paediatric acute care referral and wants to arrange transportation there is an initial call at which point there are two priorities: first is obtain a patient history and then provide advice to the remote caregiver to initiate specific therapies; second is to mobilize the specialized team to the patient. The period of time between giving initial advice while dispatching the team and the time when the team arrives, can often be a vulnerable period for the remote caregiver as well as the patient. The ability to directly visualize and assess the patient during this time, as well as assist the specialized team once they arrive may provide improvement in safety and care of the patient. It may also improve triaging and may make the stabilization and departure time more efficient.

Remote technology will be used for an initial patient assessment after being contacted by phone from the peripheral centre to transfer an acutely ill paediatric patient as assessed by the referral centre care provider. After assessment the patient will be triaged to either remain in the local community, transferred to a regional hospital that provides paediatric acute care (Prince Albert), or be transported to Royal University Hospital in Saskatoon for tertiary care. Data to be collected includes:

  • Duration of time from the beginning of the initial phone call to the first therapeutic intervention
  • Time to stabilization
  • Time to decision for disposition
  • The duration of contact with the health care provider and the patient
  • Number of scheduled follow-up contacts for a specific patient within 24 hours
  • Number of times the referring centre re-consults
  • Of the patients who triaged to stay in the local community how many were transported to the tertiary care centre within 24hrs
  • How many patients who arrived at the tertiary care centre were discharged within 24hrs
  • How many patients on arrival were deemed to be unnecessary

The nurses and physicians who are communicating with the Intensivist about the case will complete a post-encounter survey to evaluate their experience.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 69 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Remote Technology for Paediatric Patient Assessment, Stabilization and Triaging Prior to Paediatric Inter-facility Transportation: A Feasibility Study
Study Start Date : March 2015
Actual Primary Completion Date : February 2016
Actual Study Completion Date : May 2016

Arm Intervention/treatment
Experimental: Remote technology
Remote technology will be used for an initial patient assessment after being contacted by phone from the peripheral center to transfer an acutely ill pediatric patient as assessed by the referral centre care provider.
Other: Remote technology
Utilization of remote technology versus not using remote technology when triaging and managing pediatric patients in remote settings prior to pediatric specialized inter-facility transportation.

No Intervention: Control
A Nurse Practitioner or General Practitioner from a remote site has a pediatric acute care referral and arranges a transportation. There is an initial call to obtain a patient history, to provide advice to the remote caregiver to initiate specific therapies and to mobilize the specialized team to the patient.



Primary Outcome Measures :
  1. Transport number in the cases (with the robot) versus the controls (without the robot) [ Time Frame: One year ]

Secondary Outcome Measures :
  1. Tertiary care hospital length of stay in the cases versus the controls [ Time Frame: One year ]
  2. The number of patients transported to the regional hospitals in the cases (with the robot) versus the controls (without the robot) [ Time Frame: One year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Remote Technology Group Inclusion:

  • Patients ≤ 17 years from peripheral centre (Pelican Narrows Clinic and Regina General Hospital).
  • Acutely ill.
  • Being considered for medical transport.

Control Group Inclusion:

  • Patients ≤ 17 years from peripheral centre (Stony Rapids, Wollaston Lake and Sandy Bay).
  • Chosen from a pre-existing Saskatchewan paediatric transport database.

Exclusion Criteria:

  • Patients older than age 17.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02915640


Locations
Layout table for location information
Canada, Saskatchewan
Pelican Narrows Clinic (Angelique Canada Health Centre)
Pelican Narrows, Saskatchewan, Canada, S0P 0E0
Regina General Hospital
Regina, Saskatchewan, Canada, S4P 0W5
Royal University Hospital
Saskatoon, Saskatchewan, Canada, S7N0W8
Sponsors and Collaborators
University of Saskatchewan
Investigators
Layout table for investigator information
Principal Investigator: Tanya Holt, MD Clinical Assistant Professor

Publications:
Layout table for additonal information
Responsible Party: Tanya Holt, Clinical Assistant Professor, University of Saskatchewan
ClinicalTrials.gov Identifier: NCT02915640     History of Changes
Other Study ID Numbers: PITROBOT-1
First Posted: September 27, 2016    Key Record Dates
Last Update Posted: September 27, 2016
Last Verified: September 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Acute Disease
Disease Attributes
Pathologic Processes